[Nuclear receptors PPAR as a drug target in metabolic disorders].;Receptory jadrowe PPAR jako miejsce działania leków w zaburzeniach metabolicznych.

Postepy biochemii

Volumn 57, Issue 2, 2011, Pages 207-214

  Stolarczyk, Marta ^a   Gutman, Wojciech ^b   Derlacz, Rafał A ^b  

^a UNIVERSITY OF WARSAW   (Poland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

DRUG DESIGN; DRUG POTENTIATION; HUMAN; METABOLIC DISORDER; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

DIABETES MELLITUS, TYPE 2; DRUG DESIGN; HUMANS; METABOLIC DISEASES; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PPAR ALPHA; PPAR GAMMA; THIAZOLIDINEDIONES;

EID: 80053622101     PISSN: 00325422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)